He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...

Anyone who has tried to lose weight by cutting calories knows the frustration—after initial success, weight loss slows down ...

A new study has found that a once-weekly injection of semaglutide, a medication originally developed for diabetes and weight ...

Although the trial results failed to meet Novo Nordisk’s projection of 25% weight loss, the Denmark-based drugmaker said it plans to seek regulatory approval of CagriSema in early 2026.

Earlier this year, when US President Donald Trump offered to buy Greenland from Denmark, online rumours circulated that the Danish government might encourage Novo Nordisk, the Danish company behind ...

It may seem incredibly unfair that the body doesn't recognize the goal of weight loss and instead works against it by holding on to calories. Now, a new study from the University of Southern Denmark ...

It may seem incredibly unfair that the body doesn't recognize the goal of weight loss and instead works against it by holding on to calories. Now, a new study from University of Southern Denmark ...

A class action lawsuit was filed against Novo Nordisk A/S (NVO) by Levi & Korsinsky on January 24, 2025. The plaintiffs ...

Denmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the ...